NYSE:TEVAPharmaceuticals
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After The Home Ground Schizophrenia Platform Launch
Teva Pharmaceutical Industries (NYSE:TEVA) has launched Home Ground Schizophrenia Community, an online platform aimed at supporting people living with schizophrenia and their care partners through practical tools, peer-informed resources, and community-focused content.
See our latest analysis for Teva Pharmaceutical Industries.
The launch of Home Ground comes as Teva’s share price sits at US$32.40, with a 1 month share price return of 12.77% and a 1 year total shareholder return of 137.36%...